{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:47:01Z","timestamp":1790290021689,"version":"4.1.0"},"reference-count":23,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Bone marrow-derived endothelial precursor cells incorporate into neovasculature and have been successfully used as vehicles for gene delivery to brain tumors. To determine whether systemically administered Sca1+ bone marrow cells labeled with superparamagnetic iron oxide nanoparticles can be detected by in vivo magnetic resonance imaging in a mouse brain tumor model, mouse Sca1+ cells were labeled in vitro with ferumoxides-poly-l-lysine complexes. Labeled or control cells were administered intravenously to glioma-bearing severe combined immunodeficient (SCID) mice. Magnetic resonance imaging (MRI) was performed during tumor growth. Mice that received labeled cells demonstrated hypointense regions within the tumor that evolved over time and developed a continuous dark hypointense ring at a consistent time point. This effect was not cleared by administration of a gadolinium contrast agent. Histology showed iron-labeled cells around the tumor rim in labeled mice, which expressed CD31 and von Willebrand factor, indicating the transplanted cells detected in the tumor have differentiated into endothelial-like cells. These results demonstrate that MRI can detect the incorporation of magnetically labeled bone marrow-derived precursor cells into tumor vasculature as part of ongoing angiogenesis and neovascularization. This technique can be used to directly identify neovasculature in vivo and to facilitate gene therapy by noninvasively monitoring these cells as gene delivery vectors. (Blood. 2005;105:420-425)<\/jats:p>","DOI":"10.1182\/blood-2004-06-2222","type":"journal-article","created":{"date-parts":[[2004,8,27]],"date-time":"2004-08-27T00:14:41Z","timestamp":1093565681000},"page":"420-425","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":216,"title":["Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model"],"prefix":"10.1182","volume":"105","author":[{"given":"Stasia A.","family":"Anderson","sequence":"first","affiliation":[{"name":"From the Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; the Neuro-Oncology Branch, National Cancer Institute and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; and the Experimental Neuroimaging Section, Laboratory of Diagnostic Radiology Research, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Glod","sequence":"additional","affiliation":[{"name":"From the Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; the Neuro-Oncology Branch, National Cancer Institute and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; and the Experimental Neuroimaging Section, Laboratory of Diagnostic Radiology Research, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali S.","family":"Arbab","sequence":"additional","affiliation":[{"name":"From the Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; the Neuro-Oncology Branch, National Cancer Institute and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; and the Experimental Neuroimaging Section, Laboratory of Diagnostic Radiology Research, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Noel","sequence":"additional","affiliation":[{"name":"From the Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; the Neuro-Oncology Branch, National Cancer Institute and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; and the Experimental Neuroimaging Section, Laboratory of Diagnostic Radiology Research, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parwana","family":"Ashari","sequence":"additional","affiliation":[{"name":"From the Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; the Neuro-Oncology Branch, National Cancer Institute and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; and the Experimental Neuroimaging Section, Laboratory of Diagnostic Radiology Research, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard A.","family":"Fine","sequence":"additional","affiliation":[{"name":"From the Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; the Neuro-Oncology Branch, National Cancer Institute and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; and the Experimental Neuroimaging Section, Laboratory of Diagnostic Radiology Research, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Frank","sequence":"additional","affiliation":[{"name":"From the Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; the Neuro-Oncology Branch, National Cancer Institute and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; and the Experimental Neuroimaging Section, Laboratory of Diagnostic Radiology Research, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021218234099400_REF1","doi-asserted-by":"crossref","unstructured":"Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med.1971;285: 1182-1186.","DOI":"10.1056\/NEJM197111182852108"},{"key":"2020021218234099400_REF2","doi-asserted-by":"crossref","unstructured":"Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science.1997;275: 964-967.","DOI":"10.1126\/science.275.5302.964"},{"key":"2020021218234099400_REF3","doi-asserted-by":"crossref","unstructured":"Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res.1999;85: 221-228.","DOI":"10.1161\/01.RES.85.3.221"},{"key":"2020021218234099400_REF4","doi-asserted-by":"crossref","unstructured":"Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bone marrow-derived hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med.2001;7: 1194-1201.","DOI":"10.1038\/nm1101-1194"},{"key":"2020021218234099400_REF5","doi-asserted-by":"crossref","unstructured":"Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med.2003;9: 702-712.","DOI":"10.1038\/nm0603-702"},{"key":"2020021218234099400_REF6","doi-asserted-by":"crossref","unstructured":"Ferrari N, Glod J, Lee J, Kobiler D, Fine HF. Bone marrow-derived endothelial progenitor-like cells as angiogenesis-selective gene targeting vectors. Gene Ther.2003;10: 647-656.","DOI":"10.1038\/sj.gt.3301883"},{"key":"2020021218234099400_REF7","doi-asserted-by":"crossref","unstructured":"DePalma M, Venneri MA, Roca C, Naldini L. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med.2003;9: 789-795.","DOI":"10.1038\/nm871"},{"key":"2020021218234099400_REF8","doi-asserted-by":"crossref","unstructured":"Frank JA Zywicke H, Jordan EK, et al. Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad Radiol.2002;9: S484-S488.","DOI":"10.1016\/S1076-6332(03)80271-4"},{"key":"2020021218234099400_REF9","doi-asserted-by":"crossref","unstructured":"Frank JA, Miller BR, Arbab AS, et al. Clinically applicable labeling of mammalian cells and stem cells by combining (FDA)-approved superparamagnetic iron oxides and commonly available transfection agents. Radiology.2003;228: 480-487.","DOI":"10.1148\/radiol.2281020638"},{"key":"2020021218234099400_REF10","doi-asserted-by":"crossref","unstructured":"Arbab AS, Bashaw LA, Miller BR, et al. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles (Ferumoxides) and transfection agent (poly-l-lysine) for cellular MR imaging. Radiology.2003;229: 838-846.","DOI":"10.1148\/radiol.2293021215"},{"key":"2020021218234099400_REF11","doi-asserted-by":"crossref","unstructured":"Arbab AS, Bashaw LA, Miller BR, Jordan EK, Bulte JWM, Frank JA. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantation.2003;76: 1123-1130.","DOI":"10.1097\/01.TP.0000089237.39220.83"},{"key":"2020021218234099400_REF12","doi-asserted-by":"crossref","unstructured":"Bulte JWM, Zhang SC, van Gelderen P, et al. Neurotransplantation of magnetically labeled oligodendrocytes progenitors: MR tracking of cell migration and myelination. Proc Natl Acad Sci U S A.1999;96: 15256-15261.","DOI":"10.1073\/pnas.96.26.15256"},{"key":"2020021218234099400_REF13","doi-asserted-by":"crossref","unstructured":"Bulte JWM, Douglas T, Witer B, et al. Magneto-dendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol.2001;19: 1141-1147.","DOI":"10.1038\/nbt1201-1141"},{"key":"2020021218234099400_REF14","doi-asserted-by":"crossref","unstructured":"Anderson SA, Shukaliak-Quandt J, Jordan EK, et al. Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann Neurol.2004;55: 654-659.","DOI":"10.1002\/ana.20066"},{"key":"2020021218234099400_REF15","doi-asserted-by":"crossref","unstructured":"Arbab AS, Yocum GT, Wilson LB, et al. Comparison of transfection agents in forming complexes with Ferumoxides, cell labeling efficiency, and cellular viability. Mol Imaging.2004;3: 24-32.","DOI":"10.1162\/153535004773861697"},{"key":"2020021218234099400_REF16","doi-asserted-by":"crossref","unstructured":"McDonald DM, Choyke PL. Imaging of angiogenesis: from microscope to clinic. Nat Med.2003;9: 713-725.","DOI":"10.1038\/nm0603-713"},{"key":"2020021218234099400_REF17","doi-asserted-by":"crossref","unstructured":"Costuros NG, Diehn FE, Libutti SK. Molecular imaging of angiogenesis. J Cell Biochem Suppl.2002;39: 72-78.","DOI":"10.1002\/jcb.10426"},{"key":"2020021218234099400_REF18","doi-asserted-by":"crossref","unstructured":"Choyke PL, Dwyer AJ, Knopp MV Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging.2003;17: 509-520.","DOI":"10.1002\/jmri.10304"},{"key":"2020021218234099400_REF19","doi-asserted-by":"crossref","unstructured":"Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology.2002;223: 11-29.","DOI":"10.1148\/radiol.2231010594"},{"key":"2020021218234099400_REF20","doi-asserted-by":"crossref","unstructured":"Zagzag D, Amirnovin R, Greco A, et al. Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis. Lab Invest.2000;80: 837-849.","DOI":"10.1038\/labinvest.3780088"},{"key":"2020021218234099400_REF21","doi-asserted-by":"crossref","unstructured":"Cha S, Johnson G, Wadghiri YZ, et al. Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med.2003;49: 848-855.","DOI":"10.1002\/mrm.10446"},{"key":"2020021218234099400_REF22","doi-asserted-by":"crossref","unstructured":"Moore X-L, Lu J, Sun L, et al. Endothelial progenitor cells' `homing' specificity to brain tumors. Gene Ther.2004;11: 811-818.","DOI":"10.1038\/sj.gt.3302151"},{"key":"2020021218234099400_REF23","doi-asserted-by":"crossref","unstructured":"Arbab AS, Yocum GT, Kalish H, et al. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood.2004;104: 1217-1223.","DOI":"10.1182\/blood-2004-02-0655"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/1\/420\/1705021\/zh800105000420.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/1\/420\/1705021\/zh800105000420.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:29:18Z","timestamp":1581553758000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/105\/1\/420\/20010\/Noninvasive-MR-imaging-of-magnetically-labeled"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-06-2222","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,1]]}}}